MXPA04000805A - Peptidos que tienen actividad antiangiogenica. - Google Patents

Peptidos que tienen actividad antiangiogenica.

Info

Publication number
MXPA04000805A
MXPA04000805A MXPA04000805A MXPA04000805A MXPA04000805A MX PA04000805 A MXPA04000805 A MX PA04000805A MX PA04000805 A MXPA04000805 A MX PA04000805A MX PA04000805 A MXPA04000805 A MX PA04000805A MX PA04000805 A MXPA04000805 A MX PA04000805A
Authority
MX
Mexico
Prior art keywords
peptides
antiangiogenic activity
compounds
methods
angiogenesis
Prior art date
Application number
MXPA04000805A
Other languages
English (en)
Inventor
Haviv Fortuna
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MXPA04000805A publication Critical patent/MXPA04000805A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Se describen compuestos que tienen la formula A0-A1-A2-A3-A4-A5-A6-A7-A8-A9-A10, los cuales son utiles para tratar las condiciones que se originan de o se agravan por angiogenesis. Tambien se describen las composiciones farmaceuticas que comprenden estos compuestos, los metodos de tratamiento que utilizan estos compuestos, y los metodos para inhibir la angiogenesis.
MXPA04000805A 2001-07-26 2002-06-20 Peptidos que tienen actividad antiangiogenica. MXPA04000805A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/915,956 US20030050246A1 (en) 2001-07-26 2001-07-26 Peptides having antiangiogenic activity
PCT/US2002/019574 WO2003011896A1 (en) 2001-07-26 2002-06-20 Peptides having antiangiogenic activity

Publications (1)

Publication Number Publication Date
MXPA04000805A true MXPA04000805A (es) 2004-06-03

Family

ID=25436471

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000805A MXPA04000805A (es) 2001-07-26 2002-06-20 Peptidos que tienen actividad antiangiogenica.

Country Status (14)

Country Link
US (1) US20030050246A1 (es)
EP (1) EP1421107A1 (es)
JP (1) JP2005507864A (es)
AR (1) AR034890A1 (es)
BG (1) BG108587A (es)
CA (1) CA2454753A1 (es)
CZ (1) CZ2004283A3 (es)
HU (1) HUP0401629A2 (es)
MX (1) MXPA04000805A (es)
PE (1) PE20030302A1 (es)
PL (1) PL368745A1 (es)
SK (1) SK1172004A3 (es)
UY (1) UY27394A1 (es)
WO (1) WO2003011896A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067490B2 (en) * 2001-10-31 2006-06-27 Abbott Laboratories Hepta-, Octa-and nonapeptides having antiangiogenic activity
US20030228365A1 (en) * 2002-06-07 2003-12-11 Fortuna Haviv Pharmaceutical formulation
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
MY148144A (en) 2006-11-10 2013-03-15 Cara Therapeutics Inc Synthetic peptide amides
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
RU2447848C2 (ru) * 2010-07-26 2012-04-20 Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ профилактики полостных спаек

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512591A (en) * 1993-02-18 1996-04-30 President And Fellows Of Harvard College Treatments for diseases characterized by neovascularization
WO1999061476A1 (en) * 1998-05-22 1999-12-02 Abbott Laboratories Peptide antiangiogenic drugs

Also Published As

Publication number Publication date
PL368745A1 (en) 2005-04-04
PE20030302A1 (es) 2003-03-27
UY27394A1 (es) 2003-02-28
US20030050246A1 (en) 2003-03-13
HUP0401629A2 (hu) 2004-11-29
CA2454753A1 (en) 2003-02-13
AR034890A1 (es) 2004-03-24
SK1172004A3 (en) 2004-08-03
BG108587A (bg) 2005-03-31
JP2005507864A (ja) 2005-03-24
WO2003011896A1 (en) 2003-02-13
CZ2004283A3 (cs) 2004-07-14
EP1421107A1 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
AP1498A (en) Inhibitors of impdh enzyme.
DE60112609D1 (en) Pyrazolopyridine
DE602004021472D1 (en) Pyrimiidinverbindungen
MY145077A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
GB0225475D0 (en) Therapeutic agents
PL367682A1 (en) Dolastatin 10 derivatives
PL344861A1 (en) Trazinic angiogenesis inhibitiors
DE60112330D1 (en) Pyrazolopyridinderivate
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
MXPA04004134A (es) Tri-, tetra-, y pentapeptidos que tienen actividad antiangiogenica.
IL152097A0 (en) Use of pyrazole derivatives for treating infertility
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
WO2004073375A3 (en) Podophyllotoxin derivatives as antitumor agents
BG105953A (en) Method for treating copd
TW200503672A (en) 2-aminobenzoyl derivatives
HK1061355A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
MXPA04004133A (es) Di-, tri- y tetra-peptidos que tienen actividad antiangiogenica.
ATE346036T1 (de) Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen
MXPA04004131A (es) Hexa-, hepta-, y octapeptidos que tienen actividad antiangiogenica.
MXPA04004135A (es) Tetra-, penta-, hexa y heptapeptidos con actividad antiangiogenica.
MXPA04004132A (es) Hexa-, hepta-, y octapeptidos que tienen actividad antiangiogenica.
TW200505872A (en) Hepatitis C virus inhibitors
WO2001018030A3 (en) Small peptides having potent anti-angiogenic activity

Legal Events

Date Code Title Description
FA Abandonment or withdrawal